XML 63 R53.htm IDEA: XBRL DOCUMENT v3.8.0.1
Related Party Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Mar. 31, 2016
Jan. 31, 2016
May 31, 2015
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2013
Dec. 31, 2010
Related-Party Transactions (Textual) [Abstract]                  
Long-term other assets $ 2,639,354         $ 2,448,628      
Contra-research and development expense           $ 2,200,000      
GeneOne Life Sciences                  
Related-Party Transactions (Textual) [Abstract]                  
Investment owned (shares)           1,644,155      
Payment received for license granted                 $ 3,000,000
Term               20 years  
Milestone-based ownership target       35.00% 35.00%        
Proceeds from sale of intangible assets 1,000,000                
Revenue from related parties           $ 118,000 $ 167,000    
Operating expenses related to affiliated entity           1,700,000 428,000    
Accounts payable and accrued liability 107,000         710,000      
Long-term other assets 331,000         347,000      
Director                  
Related-Party Transactions (Textual) [Abstract]                  
Term     5 years            
Revenue from related parties             614,000    
Operating expenses related to affiliated entity           402,000 543,000    
Accounts receivable 117,000         1,800,000      
Expenses to reimburse     $ 3,100,000            
Award   $ 6,100,000              
Contra-research and development expense           1,800,000      
Accounts payable/accrued liabilities 820,000         589,000      
Plumbline Life Sciences                  
Related-Party Transactions (Textual) [Abstract]                  
Revenue from related parties           30,000 $ 67,000    
Accounts receivable $ 370,000         $ 400,000      
Plumbline Life Sciences | Available-for-sale Securities                  
Related-Party Transactions (Textual) [Abstract]                  
Investment owned (shares)           395,758